Koers Sansure Biotech Inc.
Aandelen
688289
CNE1000043J1
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,6 CNY | -1,21% | -2,68% | +0,26% |
Omzet 2024 * | 1,5 mld. 207 mln. 190 mln. | Omzet 2025 * | 2,01 mld. 277 mln. 256 mln. | Marktkapitalisatie | 11,24 mld. 1,55 mld. 1,43 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 329 mln. 45,43 mln. 41,88 mln. | Nettowinst (verlies) 2025 * | 458 mln. 63,24 mln. 58,3 mln. | EV/omzet 2024 * | 7,51 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 5,6 x |
K/w-verhouding 2024 * |
35
x | K/w-verhouding 2025 * |
25,1
x | Werknemers | 2.006 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 47,59% |
1 dag | -1,21% | ||
1 week | -2,68% | ||
Lopende maand | -4,20% | ||
1 maand | +4,26% | ||
3 maanden | -3,50% | ||
6 maanden | +7,87% | ||
Lopend jaar | +0,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Wu Tan
CHM | Chairman | 41 | 01-01-10 |
Zhu Peng
DFI | Director of Finance/CFO | 48 | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shan Ping Wang
BRD | Director/Board Member | 60 | 01-07-16 |
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Xia Lin Yu
BRD | Director/Board Member | 45 | 01-12-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.04% | 1 M€ | -15,71% | - | |
0.12% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 19,6 | -1,21% | 1 860 936 |
23-05-24 | 19,84 | -2,31% | 2 477 452 |
22-05-24 | 20,31 | +0,05% | 1 979 594 |
21-05-24 | 20,3 | -0,05% | 2 479 542 |
20-05-24 | 20,31 | +0,84% | 2 610 400 |
slotkoers Shanghai S.E., 24 mei 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,26% | 1,55 mld. | |
-4,92% | 12,27 mld. | |
-5,82% | 7,99 mld. | |
+5,43% | 5,69 mld. | |
+26,16% | 5,42 mld. | |
-9,58% | 4,13 mld. | |
-59,63% | 2,7 mld. | |
+8,44% | 2,6 mld. | |
-3,70% | 2,38 mld. | |
+21,00% | 2,1 mld. |